To Explore the Factors Affecting the Effectiveness of Smoking Cessation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03474783 |
|
Recruitment Status :
Completed
First Posted : March 23, 2018
Last Update Posted : March 23, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Objectives:
Promoting quitting smoking and training smoking cessation educators in hospital, school, community, and workplace was being vigorously pushed by Health Promotion Administration. Since the implementation of the second-generation smoking cessation program by Health Promotion Administration, both the general public and medical institutions have worked with greater vitality to practice and promote quitting smoking. However, studies on smoking cessation in the inpatient remain inadequate. Increasing cessation motivation for inpatient smokers and evaluating their nicotine dependence are essential. In this study, we aimed to explore the factors that might influence the smoking cessation in the inpatients.
Method: A cross-sectional questionnaire survey was conducted on inpatients participants at the smoking cessation.
Questionnaire comprising(1)Demographic characteristics: age, sex, marital status, education, (2)physiological factors(concentration of carbon monoxide, nicotine dependence, disease severity),(3)psychological factors(psychological dependence on smoking , smoking cessation stages of behavior change, smoking cessation self-efficacy), (4)Social Factor: social support,(5)smoking Behavior indicators: smoked, daily cigarette consumption, smoking experience. After giving health education cessation of treatment one month, three months and six months, interviewed by telephone quitting behavior index contains daily cigarette consumption, quit rates point.
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Smoking Cessation | Behavioral: Health education | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 155 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | To Explore the Factors Affecting the Effectiveness of Smoking Cessation |
| Actual Study Start Date : | September 22, 2015 |
| Actual Primary Completion Date : | June 30, 2016 |
| Actual Study Completion Date : | February 2, 2017 |
| Arm | Intervention/treatment |
|---|---|
| Experimental: multidisciplinary intervention |
Behavioral: Health education
Stages of change of intentions to cease smoking of participants at the baseline were determined, and a personal-tailored health education was accordingly delivered. |
- point prevalence abstinence [ Time Frame: 1 month after intervention ]whether quitting smoking
- point prevalence abstinence [ Time Frame: 3 months after intervention ]whether quitting smoking
- point prevalence abstinence [ Time Frame: 6 months after intervention ]whether quitting smoking
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- being a current smoker (who had smoked more than 100 cigarettes in their lifetime),
- aged > 20 years,
- with clear consciousness,
- being able to communicate using Mandarin or Taiwanese
Exclusion Criteria:
- with acute psychiatric disorders,
- inability to complete the questionnaire
| Responsible Party: | Cathay General Hosp. IRB, Nursing Supervisor, Cathay General Hospital |
| ClinicalTrials.gov Identifier: | NCT03474783 |
| Other Study ID Numbers: |
CGH-P 104061 |
| First Posted: | March 23, 2018 Key Record Dates |
| Last Update Posted: | March 23, 2018 |
| Last Verified: | March 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

